Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1648908 | 0.82 | METAP2 (0.34) | NAT1METAP2 | |
| SCHEMBL1648191 | 0.80 | METAP2 (0.39) | NAT1METAP2 | |
| SCHEMBL18784217 | 0.71 | GBA1 (0.34) | NAT1METAP2 | |
| SCHEMBL6844868 | 0.70 | METAP2 (0.35) | NAT1METAP2 | |
| SCHEMBL1648269 | 0.69 | METAP2 (0.43) | NAT1METAP2 | |
| SCHEMBL1647756 | 0.69 | METAP2 (0.53) | NAT1METAP2 | |
| SCHEMBL1648322 | 0.69 | METAP2 (0.34) | NAT1METAP2 | |
| SCHEMBL1648491 | 0.69 | METAP2 (0.36) | NAT1METAP2 | |
| SCHEMBL1648460 | 0.68 | NAT1 (0.36) | NAT1METAP2 | |
| SCHEMBL6844906 | 0.68 | METAP2 (0.40) | NAT1METAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2486004-B1 | SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY | ZAFGEN INC (US) | 2017-05-03 | — | — | EP | disclosed |